Literature DB >> 2191013

Use of HL cells for improved isolation and passage of Chlamydia pneumoniae.

L D Cles1, W E Stamm.   

Abstract

We compared growth of the recently discovered respiratory pathogen Chlamydia pneumoniae in McCoy, HeLa 229, BHK-21, and HL cells. When cells were not pretreated with DEAE-dextran, HL cells had significantly higher mean numbers of inclusion-forming units (IFUs) on initial inoculation than the other cell lines. When cells were pretreated with DEAE-dextran, HeLa 229 and HL cells had equivalent mean numbers of IFUs on initial inoculation. HL cells had strikingly higher mean numbers of IFUs in passage than HeLa 229, BHK-21, or McCoy cells. In addition, HL cells did not require pretreatment with DEAE-dextran and could be used from 2 to 4 days after seeding. We conclude that HL cells are an excellent cell culture system for laboratory propagation of C. pneumoniae and may be a more sensitive cell line for initial isolation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191013      PMCID: PMC267841          DOI: 10.1128/jcm.28.5.938-940.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

2.  Isolation of a gene encoding a Chlamydia sp. strain TWAR protein that is recognized during infection of humans.

Authors:  L A Campbell; C C Kuo; R W Thissen; J T Grayston
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  HL cells, a sensitive line for the isolation and propagation of respiratory syncytial virus.

Authors:  J J Cavallaro; A S Monto
Journal:  Proc Soc Exp Biol Med       Date:  1972-06

4.  Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran.

Authors:  C Kuo; S Wang; B B Wentworth; J T Grayston
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

5.  Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.

Authors:  E Y Chi; C C Kuo; J T Grayston
Journal:  J Bacteriol       Date:  1987-08       Impact factor: 3.490

Review 6.  Microbiology Diagnosis of chlamydia trachomatis infection.

Authors:  K T Ripa
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Microtest procedure for isolation of Chlamydia trachomatis.

Authors:  B L Yoder; W E Stamm; C M Koester; E R Alexander
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

8.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

9.  Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

10.  Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.

Authors:  J T Grayston; C Mordhorst; A L Bruu; S Vene; S P Wang
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

View more
  25 in total

1.  Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  P M Roblin; W Dumornay; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Diagnostic tests should be used for sexually transmitted chlamydia.

Authors:  W E Stamm
Journal:  West J Med       Date:  1990-11

3.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.

Authors:  Laura Mannonen; Eveliina Markkula; Mirja Puolakkainen
Journal:  Med Microbiol Immunol       Date:  2011-01-30       Impact factor: 3.402

4.  Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsis.

Authors:  G Blomqvist; L Wesslén; C Påhlson; E Hjelm; B Pettersson; T Nikkilä; U Allard; O Svensson; M Uhlén; B Morein; G Friman
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

Review 5.  Current and past strategies for bacterial culture in clinical microbiology.

Authors:  Jean-Christophe Lagier; Sophie Edouard; Isabelle Pagnier; Oleg Mediannikov; Michel Drancourt; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

6.  Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion.

Authors:  Juha T Korhonen; Mirja Puolakkainen; Reetta Häivälä; Tuula Penttilä; Anu Haveri; Eveliina Markkula; Riitta Lahesmaa
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

7.  Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots.

Authors:  H M Freidank; A S Herr; E Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

8.  Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland.

Authors:  M R Ekman; M Leinonen; H Syrjälä; E Linnanmäki; P Kujala; P Saikku
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

9.  The incidence of Chlamydia pneumoniae lower respiratory tract infections among university students in northern California.

Authors:  D K Katzman; A C Tipton; I F Litt; I M Friedman; R W Emmons; J Schachter
Journal:  West J Med       Date:  1991-08

10.  Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene.

Authors:  C A Gaydos; T C Quinn; L D Bobo; J J Eiden
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.